MONTREAL, March 12 /CNW Telbec/ - ORTHOsoft Inc. (TSX-V: OSH), a leader
in computer-assisted systems that increase the accuracy of orthopaedic knee,
hip and spine procedures, announced today that Yvan Beaudoin has been
appointed as chief operating officer.
"Yvan Beaudoin has played a pivotal role in the company's successful
transition from an R&D to a sales and marketing company for the last 4 years
said Dr. Louis-Philippe Amiot, Chairman and CEO of ORTHOsoft. We are all
confident that he will lead ORTHOsoft forward as a premier best-in-class
provider in computer assisted orthopedic surgery", added Dr. Amiot.
Mr. Beaudoin's new roles will be to continue accelerate the sale force
deployment in the United States and Europe as well as implementing new
strategies with ORTHOsoft's distributors, customers and partners to speed up
the revenue growth.
About Yvan Beaudoin
Mr. Beaudoin started with ORTHOsoft in March 2003 and was Vice-President,
Sales and Marketing since January 2004. Mr. Beaudoin is a science graduate of
McGill University, 1978. He also completed a Master's Degree in Business
Administration at the University of Toronto in 1986. He has experience at the
senior management level, with emphasis on marketing and sales, including
product development and market expansion. He has worked for both small and
large businesses in the medical sector and has gained international experience
in living and working in Europe and the USA for over 6 years.
The Company has a total of 3,757,036 options issued as of March 12, 2007.
Following the departure of M. John Feilders as of January 31, 2007,
M. Feilders holds a total of 400,000 options. These options are exercisable at
a price of $0.40 until June 21, 2016 (the 10 years expiry date having been
approved by the TSX Venture Exchange).
Orthopaedic Surgery Market
In North America, surgeons perform over one million orthopaedic knee and
hip implant surgeries annually. Leading orthopaedic surgeons predict that
computer assisted surgery will become a standard of care in implant surgery.
Clinical studies show that computer assisted surgery in orthopaedics can
improve the accuracy of surgery by over 20% compared to conventional surgery,
and also significantly reduce patient post-operative pain, improve function,
and quality of life, compared to conventional surgery.
ORTHOsoft Inc. (TSX-V: OSH), www.orthosoft.ca, founded in 1995, develops
and markets best-in-class medical software, instruments and computerized
systems to assist orthopaedic surgeons to increase accuracy in hip, knee and
spine implant surgery. FDA cleared, ORTHOsoft's patented software solutions
are developed by surgeons for surgeons, resulting in intuitive and easy-to-use
navigation that tracks surgical flow and provides surgeons with real-time data
that helps to improve the surgical process and patient outcomes. For more
information about ORTHOsoft, please visit www.orthosoft.ca.
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, inherently involve numerous risks
and uncertainties, known and unknown, many of which are beyond the control of
ORTHOsoft Inc. Such risks include, but are not limited to: the impact of
general economic conditions, general conditions in the medical industry, and
changes to the competitive environment in the jurisdictions in which ORTHOsoft
does business, regulatory changes to the health care industry, and adequate
protection of the proprietary interests of the Company. Consequently, actual
future results may differ materially from the anticipated results expressed in
the forward-looking statements. The reader should not place undue reliance on
the forward-looking statements included in this press release. These
statements speak only as of the date made, and ORTHOsoft is under no
obligation and disavows any intention to update or revise such statements as a
result of any event, circumstances, or otherwise.
For further information:
For further information: Echoes Financial Network Inc.: Investors and
Media: Dominic Sicotte, 1-866-633-9551, email@example.com;
ORTHOsoft Inc.: Peggy Katsiroumbas, CA, Chief Financial Officer, (514)
861-4074, ext. 221, firstname.lastname@example.org; Dr. Louis-Philippe Amiot,
Chairman and CEO, (514) 861-4074, ext. 201, email@example.com